lanthaler
arGEN-X appoints Evotec chief executive
April 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Evotec, arGEN-X, lanthaler
Belgium-based clinical stage human therapeutic antibody firm arGEN-X has appointed Dr Werner Lanthaler to its supervisory board.
 Lanthaler is currently …
Latest content
October 28, 2026
Acumetis CEO Herspiegel steps down as Burden assumes role
October 27, 2026
